Szela Mary T

CIK 000141028912 companiesWESTMINSTER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001410289

Recent Transactions

50 trades

Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2026-02-23$4.10/sh+30,487→ 773,289 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2025-11-24+250,000→ 1,578,182 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-11-24+125,000→ 442,802 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-11-24+300,000→ 742,802 total
Award
Absci Corp$ABSI
Stock Option (right to buy)
2025-07-07+178,400→ 178,400 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2025-06-05+28,500→ 28,500 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-02-18+21,089→ 465,348 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-30$5.28/sh+5,010→ 444,259 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-29$5.03/sh+5,030→ 439,249 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-28$5.12/sh+4,716→ 434,219 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2025-01-27+240,000→ 240,000 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-27$5.42/sh+4,826→ 429,503 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2025-01-27+40,000→ 424,677 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2024-09-13$4.83/sh+1,295→ 378,677 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2024-09-13$5.00/sh+6,000→ 384,677 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2024-09-12$5.20/sh+7,520→ 377,382 total
Purchase
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2024-09-10$4.97/sh+5,000→ 369,862 total
Award
Omega Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-20+25,000→ 25,000 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2024-06-05+26,000→ 26,000 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2024-02-13+125,000→ 317,802 total
Award
TriSalus Life Sciences, Inc.$TLSI
Common Stock
2024-02-13+84,899→ 364,862 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2024-02-13+288,750→ 288,750 total
Award
TriSalus Life Sciences, Inc.$TLSI
Employee Stock Option (right to buy)
2023-08-14+172,500→ 172,500 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−40,000→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Common Stock
2023-06-16−2,071→ 0 total
Disposition to Issuer
Prometheus Biosciences, Inc.
Stock Option (right to buy)
2023-06-16−20,500→ 0 total
Award
Omega Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-07+18,118→ 18,118 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2023-05-31+26,000→ 26,000 total
Award
Prometheus Biosciences, Inc.
Common Stock
2023-05-19+2,071→ 2,071 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2022-06-21+23,000→ 23,000 total
Award
Omega Therapeutics, Inc.
Option (Right to Buy)
2022-06-08+18,118→ 18,118 total
Award
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2022-05-19+20,500→ 20,500 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2021-06-22+23,000→ 23,000 total
Award
Prometheus Biosciences, Inc.
Stock Option (Right to Buy)
2021-03-11+40,000→ 40,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2021-01-11+20,000→ 20,000 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2020-06-24+23,000→ 23,000 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-06-22$2.50/sh+14,997→ 14,997 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-06-22$12.37/sh+20,000→ 54,997 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-06-22−20,000→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-06-22−14,997→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-06-22−20,000→ 0 total
Sale
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-06-22$17.58/sh−54,997→ 0 total
Exercise/Conversion
Coherus Oncology, Inc.$CHRS
Common Stock, $0.0001 par value
2020-06-22$10.05/sh+20,000→ 34,997 total
Award
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2020-06-18+3,333→ 3,333 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2020-01-10+20,000→ 20,000 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2019-06-25+13,000→ 13,000 total
Award
ALIMERA SCIENCES INC
Stock Option (Right to Buy)
2019-06-19+50,000→ 50,000 total
Award
Coherus Oncology, Inc.$CHRS
Stock Option (Right to Buy)
2019-01-11+20,000→ 20,000 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2018-11-06+30,000→ 30,000 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2018-11-06+7,583→ 7,583 total

Companies

Recent Filings

Address

6272 W. 91ST AVENUE

WESTMINSTER, CO, 80031

View on SEC.gov